Kevin E. Lofton - 15 Oct 2026 Form 4 Insider Report for Medtronic plc (MDT)

Reporting relationship: Director
Issuer ticker: MDT
Reported as of: 15 Oct 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Oct 2026, 17:18:02 UTC
Prior SEC filing: 13 Oct 2026
Source filing: View source filing
Reporting owner signature: /s/ Patricia Walesiewicz, attorney-in-fact

Filing notes and source

Key filing fact

Kevin E. Lofton filed Form 4 for Medtronic plc (MDT) on 21 Oct 2026.

Key facts

This page summarizes Kevin E. Lofton's Form 4 filing for Medtronic plc (MDT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Oct 2026, 17:18.

Change

Previous filing in this sequence was filed on 13 Oct 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001468818 Primary reporting owner

Lofton Kevin E

Relationship: Director
Address: C/O MEDTRONIC, 710 MEDTRONIC PARKWAY, MINNEAPOLIS
Signature: /s/ Patricia Walesiewicz, attorney-in-fact
Signature date: 21 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDT transaction

Ordinary Shares

Other

Transaction value
Shares: -182
Change %: -1.8%
Price
Shares after: 9,977
Date: 15 Oct 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On October 15, 2026, 182 Medtronic plc ("Medtronic") ordinary shares beneficially owned by the Reporting Person were accepted for exchange in Medtronic's exchange offer for shares of common stock of MiniMed Group, Inc. ("MiniMed"). Pursuant to the exchange offer, the Reporting Person received 836 shares of MiniMed common stock based on the final exchange ratio of 4.5939 shares of MiniMed common stock for each Medtronic ordinary share accepted.

Footnote F2

Includes 19 shares acquired through dividend reinvestment since the last report filed by the reporting person.